Nucleic Acid Biochemistry Practice Questions

Q: Beta-alanine is formed from which of the following?

Cytosine and uracil. **Explanation:** The correct answer is **Cytosine and uracil**. This question tests your knowledge of the catabolism of nitrogenous bases. **1. Why the correct answer is right:** Pyrimidines (Cytosine, Uracil, and Thymine) undergo catabolism to produce highly soluble end-products. * **Cytosine** is first deaminated to **Uracil**. * Uracil is then reduced to dihydrouracil and eventually cleaved to form **$\beta$-alanine**, $CO_2$, and $NH_3$. * Therefore, both Cytosine and Uracil serve as precursors for $\beta$-alanine. $\beta$-alanine is a non-proteinogenic amino acid that is later used in the synthesis of Carnosine and Anserine (dipeptides found in muscle). **2. Why the incorrect options are wrong:** * **Option A & D (Adenosine):** Adenosine is a purine. Purine catabolism in humans follows a different pathway, leading to the formation of **Uric acid** as the final end-product, not amino acids. * **Option A (Thymine):** While Thymine is a pyrimidine, its catabolism follows a parallel pathway that produces **$\beta$-aminoisobutyrate** (not $\beta$-alanine). * **Option C (Cytosine alone):** While Cytosine does form $\beta$-alanine, Uracil does as well; therefore, Option B is the more complete and accurate choice. **High-Yield Clinical Pearls for NEET-PG:** * **End-products of Pyrimidine Catabolism:** Uracil/Cytosine $\rightarrow$ $\beta$-alanine; Thymine $\rightarrow$ $\beta$-aminoisobutyrate. * **Solubility:** Unlike purine end-products (uric acid), pyrimidine end-products are highly water-soluble; thus, pyrimidine overproduction does not lead to conditions like Gout. * **$\beta$-aminoisobutyrate:** Increased urinary excretion of this metabolite is a marker for high DNA turnover (e.g., in leukemia or post-radiotherapy).

Q: All of the following molecules are a part of the synthesis of a purine ring except?

Lysine. **Explanation:** The synthesis of the purine ring (Adenine and Guanine) is a complex process where the ring is built atom-by-atom directly onto a ribose-5-phosphate scaffold. The purine nucleus is a bicyclic structure consisting of a five-membered imidazole ring fused to a six-membered pyrimidine ring. **Why Lysine is the correct answer:** **Lysine** is a basic amino acid that does not contribute any atoms to the purine ring. It is primarily involved in protein synthesis and ketogenic metabolism. **Breakdown of the Purine Ring Precursors (Incorrect Options):** The atoms of the purine ring are derived from specific donors: * **Glycine (Option B):** Contributes C4, C5, and N7. It is the only amino acid that provides both carbon and nitrogen atoms to the ring. * **Glutamine (Option C):** The amide group of glutamine provides N3 and N9. * **Aspartate (Option D):** Provides the N1 atom. * **Other contributors:** **CO₂** (C6) and **N10-formyl tetrahydrofolate** (C2 and C8). **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** The conversion of PRPP to 5-phosphoribosylamine by the enzyme **PRPP glutamyl amidotransferase**. * **First purine formed:** Inosine Monophosphate (IMP) is the parent purine nucleotide. * **Drug Link:** **Methotrexate** and **Sulfonamides** interfere with purine synthesis by inhibiting folate metabolism, which is essential for providing C2 and C8 atoms. * **Mnemonic:** "Pure **A**s **G**old" (Purines: **A**denine, **G**uanine) and remember **COGS** (Carbon dioxide, Other [Folate], Glutamine, Glycine, Serine/Aspartate) as contributors.

Q: Base stacking of DNA is done by:

Hyperchromicity. ### Explanation **Correct Answer: C. Hyperchromicity** **Underlying Concept:** The nitrogenous bases in a double-stranded DNA (dsDNA) molecule are stacked closely together. This **base stacking** and the hydrogen bonding between strands shield the bases, limiting their ability to absorb UV light. When DNA is denatured (the strands separate and stacking is lost), the absorbance of UV light at **260 nm** increases significantly. This phenomenon is known as **Hyperchromicity** (or the Hyperchromic shift). Therefore, the degree of base stacking is inversely monitored by measuring hyperchromicity; as stacking decreases, hyperchromicity increases. **Analysis of Incorrect Options:** * **A. Linear dichromicity:** This refers to the difference in absorption of light polarized parallel and perpendicular to an orientation axis. While used to study DNA orientation, it is not the standard measure for base stacking. * **B. Hypochromicity:** This is the *decrease* in light absorption. dsDNA is hypochromic relative to single-stranded DNA (ssDNA) because of base stacking. However, in the context of biochemical assays and the "Hyperchromic effect," the transition to an unstacked state is defined by hyperchromicity. * **D. Electrophoresis:** This is a technique used to separate DNA fragments based on their **size and charge** (moving toward the anode), not for measuring molecular stacking interactions. **High-Yield Clinical Pearls for NEET-PG:** * **Melting Temperature (Tm):** The temperature at which 50% of DNA is denatured. Tm is directly proportional to the **G-C content** (due to 3 hydrogen bonds) and the length of the DNA. * **Absorbance Peak:** DNA and RNA absorb maximally at **260 nm** due to the conjugated double bonds in purines and pyrimidines. * **Purity Ratio:** A 260/280 nm absorbance ratio of **~1.8** is considered pure for DNA; a ratio of **~2.0** is pure for RNA. If the ratio is lower, it indicates protein contamination.

Q: What is the most abundant nucleotide in the body?

ATP. **Explanation:** **ATP (Adenosine Triphosphate)** is the most abundant nucleotide in the human body because it serves as the primary "universal energy currency" of the cell. It is continuously synthesized and consumed to power essential biological processes, including muscle contraction, active transport (like the Na+/K+ ATPase pump), and biosynthetic reactions. In a typical cell, the concentration of ATP is approximately **2–10 mM**, which is significantly higher than that of other nucleoside triphosphates. **Analysis of Incorrect Options:** * **GTP (Guanosine Triphosphate):** While crucial for protein synthesis, gluconeogenesis, and G-protein coupled receptor (GPCR) signaling, its cellular concentration is much lower than ATP. * **UTP (Uridine Triphosphate):** Primarily used in glycogen synthesis (UDP-glucose) and polysaccharide metabolism. It is present in lower quantities compared to adenine nucleotides. * **DTP:** This is not a standard physiological nucleotide. Deoxyribonucleotides (like dATP) are used for DNA synthesis but exist in much smaller pools than their ribonucleotide counterparts. **High-Yield Clinical Pearls for NEET-PG:** * **Energy Charge:** The ratio of ATP to AMP/ADP regulates key metabolic pathways. High ATP inhibits catabolic enzymes (e.g., PFK-1 in glycolysis) and activates anabolic pathways. * **Total Body Content:** Although the concentration is high, the body does not "store" ATP. The total amount of ATP in the body is only about 100g, but its **turnover rate** is massive; an average adult recycles their body weight in ATP every day. * **Adenine Nucleotide Pool:** ATP, ADP, and AMP together form the adenine nucleotide pool, which is the largest nucleotide pool in any tissue.

Q: Which non-coding RNA contains abnormal purine and pyrimidine bases?

tRNA. **Explanation:** **1. Why tRNA is the correct answer:** Transfer RNA (tRNA) is unique among non-coding RNAs because it undergoes extensive post-transcriptional modifications. Approximately 10–15% of the nucleotides in a mature tRNA molecule are **modified or "abnormal" bases**. These modifications are essential for stabilizing the tRNA structure (cloverleaf model) and ensuring precise codon-anticodon recognition. Key examples of these abnormal bases include: * **Pseudouridine (ψ):** Found in the TψC arm. * **Dihydrouridine (D):** Found in the D-arm. * **Inosine (I):** Often found in the wobble position of the anticodon. * **Ribothymidine (T):** Unlike DNA, thymine is present in tRNA. **2. Why other options are incorrect:** * **Options B, C, and D (rRNAs):** Ribosomal RNAs (23S, 16S, and 5S) are the structural and catalytic components of ribosomes. While rRNA does undergo some modifications (like methylation), they primarily consist of the standard four bases (Adenine, Guanine, Cytosine, and Uracil). The density and variety of modified bases in rRNA are significantly lower than in tRNA. **3. NEET-PG High-Yield Clinical Pearls:** * **Cloverleaf vs. L-shape:** tRNA has a 2D "Cloverleaf" secondary structure but a 3D "L-shaped" tertiary structure. * **The 3' End:** All tRNAs end in the sequence **CCA-3'**, which is the attachment site for amino acids (added post-transcriptionally). * **Wobble Hypothesis:** Inosine at the 5' end of the anticodon allows a single tRNA to recognize multiple codons, providing economy in the genetic code. * **Enzyme:** Aminoacyl-tRNA synthetase is the "true translator" of the genetic code, as it attaches the correct amino acid to its corresponding tRNA.

Q: Which of the following nitrogenous bases is seen in RNA but not in DNA?

Uracil. ### Explanation **Core Concept: Nitrogenous Bases in Nucleic Acids** Nucleic acids (DNA and RNA) are composed of nucleotides, which consist of a pentose sugar, a phosphate group, and a nitrogenous base. These bases are categorized into **Purines** (Adenine and Guanine) and **Pyrimidines** (Cytosine, Thymine, and Uracil). The fundamental difference between DNA and RNA lies in their pyrimidine composition: * **DNA** contains Adenine (A), Guanine (G), Cytosine (C), and **Thymine (T)**. * **RNA** contains Adenine (A), Guanine (G), Cytosine (C), and **Uracil (U)**. Therefore, **Uracil** is the specific base found in RNA that replaces Thymine. **Analysis of Options:** * **Option A (Adenosine):** This is a *nucleoside* (Adenine + Ribose), not a nitrogenous base. Adenine itself is found in both DNA and RNA. * **Option B (Guanine):** This is a purine base present in both DNA and RNA. * **Option D (Thymine):** This is a pyrimidine base found exclusively in DNA (with rare exceptions in tRNA). **High-Yield NEET-PG Pearls:** 1. **Chemical Difference:** Thymine is also known as **5-methyluracil**. The presence of the methyl group in DNA makes it more stable and resistant to oxidative deamination. 2. **Base Pairing:** In RNA, Uracil forms two hydrogen bonds with Adenine (A=U). 3. **Deamination:** Cytosine can spontaneously deaminate to form Uracil. DNA uses Thymine instead of Uracil so the cell can easily recognize and repair these "accidental" Uracils via the Base Excision Repair (BER) pathway using the enzyme **Uracil DNA Glycosylase**. 4. **Sugar Difference:** DNA contains 2-deoxyribose, while RNA contains ribose.

Q: The salvage pathway of purine biosynthesis is important for which of the following tissues?

RBCs. **Explanation:** The **Salvage Pathway** of purine biosynthesis involves the recycling of free purine bases (adenine, guanine, and hypoxanthine) into nucleotides. This process is energetically more efficient than the *de novo* pathway, which requires significant ATP and amino acids. **Why RBCs are the correct answer:** Mature Red Blood Cells (RBCs) lack a nucleus and mitochondria, and they do not possess the complete enzymatic machinery required for **de novo purine synthesis** (specifically, they lack the multi-enzyme complexes needed to build the purine ring from scratch). Consequently, RBCs are entirely dependent on the salvage pathway to maintain their nucleotide pool. They take up pre-formed bases from the blood (often released by the liver) and convert them into nucleotides using enzymes like **HGPRT** (Hypoxanthine-Guanine Phosphoribosyltransferase) and **APRT**. Brain tissue also relies heavily on the salvage pathway for similar reasons. **Why other options are incorrect:** * **A. Liver:** The liver is the primary site for **de novo purine synthesis**. It synthesizes nucleotides from basic precursors and exports free bases/nucleosides to other peripheral tissues. * **C & D. Kidney and Lung:** While these tissues can utilize the salvage pathway, they possess the metabolic capacity for *de novo* synthesis and are not exclusively dependent on salvage mechanisms like RBCs. **High-Yield Clinical Pearls for NEET-PG:** * **Lesch-Nyhan Syndrome:** Caused by a deficiency of **HGPRT**. It leads to an inability to salvage hypoxanthine and guanine, resulting in excessive uric acid production and characteristic self-mutilation. * **Energy Cost:** *De novo* synthesis consumes **6 high-energy phosphates** per IMP molecule, whereas salvage requires only **1 (from PRPP)**. * **Key Enzyme:** PRPP (Phosphoribosyl pyrophosphate) is the essential substrate for both *de novo* and salvage pathways.

Q: Which of the following is a disorder of purine metabolism?

Gout. **Explanation:** **Correct Answer: B. Gout** Gout is a metabolic disorder characterized by **hyperuricemia** (elevated levels of uric acid in the blood). Uric acid is the final breakdown product of **purine catabolism** (adenine and guanine) in humans. When uric acid levels exceed solubility limits, monosodium urate crystals deposit in joints and soft tissues, leading to acute inflammatory arthritis. Key enzymes involved in purine metabolism often linked to gout include PRPP synthetase (overactivity) and HGPRT (deficiency in Lesch-Nyhan syndrome). **Analysis of Incorrect Options:** * **A. Hyperammonemia:** This is a disorder of the **Urea Cycle** (protein/amino acid metabolism). It occurs when the liver cannot convert toxic ammonia into urea, often due to deficiencies in enzymes like Ornithine Transcarbamylase (OTC). * **C. Orotic aciduria:** This is a disorder of **pyrimidine metabolism**. It is typically caused by a deficiency in the bifunctional enzyme UMP synthase, leading to an accumulation of orotic acid, megaloblastic anemia, and growth retardation. * **D. Hartnup disease:** This is a disorder of **amino acid transport**. It involves a defect in the transport of neutral amino acids (specifically Tryptophan) in the renal tubules and intestines, leading to pellagra-like symptoms. **High-Yield NEET-PG Pearls:** * **Rate-limiting step of Purine Synthesis:** Glutamine-PRPP amidotransferase. * **Lesch-Nyhan Syndrome:** An X-linked recessive deficiency of **HGPRT** (Salvage pathway), presenting with self-mutilation, hyperuricemia, and mental retardation. * **Von Gierke’s Disease:** A glycogen storage disease that causes secondary gout due to increased pentose phosphate pathway activity, leading to excess ribose-5-phosphate and PRPP. * **Drug of Choice:** **Allopurinol** (a suicide inhibitor of Xanthine Oxidase) is used for chronic gout to decrease uric acid production.

Q: Which of the following provides the N1 atom of the purine ring?

Aspartate. The synthesis of the purine ring (Adenine and Guanine) is a high-yield topic for NEET-PG. The purine nucleus is constructed on a ribose-5-phosphate base through a series of steps where specific atoms are donated by various molecules. ### **Explanation of the Correct Answer** **B. Aspartate** is the correct answer. In the de novo synthesis of purines, the **N1 atom** is derived from the amino group of **Aspartate**. This occurs during the step where 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) is formed. Additionally, Aspartate provides the nitrogen atom for the conversion of Inosine Monophosphate (IMP) to Adenosine Monophosphate (AMP). ### **Analysis of Incorrect Options** * **A. Glycine:** Glycine is a major contributor, providing **C4, C5, and N7** atoms. It is the only amino acid that is incorporated into the ring in its entirety. * **C. Glutamine:** Glutamine provides the **N3 and N9** atoms via its amide group. * **D. Asparagine:** While structurally similar to aspartate, asparagine does not serve as a nitrogen donor in the purine biosynthetic pathway. ### **High-Yield Facts for NEET-PG** To master purine synthesis, remember the "Source Map" of the purine ring: * **N1:** Aspartate * **C2 & C8:** Respiratory $CO_2$ (C2) and $N^{10}$-formyl tetrahydrofolate (C8) * **N3 & N9:** Glutamine (Amide group) * **C4, C5, & N7:** Glycine (The whole molecule) * **C6:** $CO_2$ (via carboxylation) **Clinical Pearl:** The rate-limiting step of purine synthesis is catalyzed by **PRPP glutamyl amidotransferase**, which is inhibited by the end-products AMP and GMP (feedback inhibition). Drugs like **Methotrexate** interfere with purine synthesis by limiting the availability of THF, which provides the C2 and C8 atoms.

Question 1

Beta-alanine is formed from which of the following?

Accepted Answer

Cytosine and uracil

Answer

Adenosine and thymine

Answer

Cytosine alone

Answer

Adenosine alone

Question 2

All of the following molecules are a part of the synthesis of a purine ring except?

Accepted Answer

Lysine

Answer

Glycine

Answer

Glutamine

Answer

Aspartate

Question 3

Base stacking of DNA is done by:

Accepted Answer

Hyperchromicity

Answer

Linear dichromicity

Answer

Hypochromicity

Answer

Electrophoresis

Question 4

What is the most abundant nucleotide in the body?

Accepted Answer

ATP

Answer

GTP

Answer

UTP

Answer

DTP

Question 5

Which non-coding RNA contains abnormal purine and pyrimidine bases?

Accepted Answer

tRNA

Answer

23S rRNA

Answer

16S rRNA

Answer

5S rRNA

Question 6

What are nucleotides?

Accepted Answer

Phosphorylated nucleosides

Answer

Heterocyclic compounds

Answer

N-Glycosides

Answer

O-Glycosides

Question 7

Which of the following nitrogenous bases is seen in RNA but not in DNA?

Accepted Answer

Uracil

Answer

Adenosine

Answer

Guanine

Answer

Thymine

Question 8

The salvage pathway of purine biosynthesis is important for which of the following tissues?

Accepted Answer

RBCs

Answer

Liver

Answer

Kidney

Answer

Lung

Question 9

Which of the following is a disorder of purine metabolism?

Accepted Answer

Gout

Answer

Hyperammonemia

Answer

Orotic aciduria

Answer

Hartnup disease

Question 10

Which of the following provides the N1 atom of the purine ring?

Accepted Answer

Aspartate

Answer

Glycine

Answer

Glutamine

Answer

Asparagine

Nucleic Acid Biochemistry — MCQs

Nucleic Acid Biochemistry — MCQs

On this page

Practice by Chapter

Want unlimited practice?